X Close

UCL Department of Science, Technology, Engineering and Public Policy

Home

Applied in Focus. Global in Reach

Menu

Science funding for crisis response and long-term resilience

c.washbourne5 February 2021

By Carla-Leanne Washbourne, Julius Mugwagwa, Remy Twiringiyimana and Anne-Marie Kagwesage

As we enter the second year of the COVID-19 pandemic, many countries are still struggling to cope with ongoing and evolving challenges brought by the virus. Governments are actively responding, day to day, with new or improved guidance for their population, based on the most up to date understanding of the pandemic, drawing on cutting edge insights from a range of different research fields.

Medic in covid testing centre

“COVID-19 testing” by World Bank Photo Collection is licensed under CC BY-NC-ND 2.0

In the shadow of this evolving crisis, the line between short term response and long-term sustained management has become more and more blurred. The impact of the COVID-19 pandemic is exacerbated by, runs in parallel to, and draws focus from many other critical and long-term social and environmental issues, including demographic shifts, urbanisation and the climate and extinction crises. Institutions tasked with supporting national systems of science and innovation have a huge role to play in the response to all of these challenges. For them, the pandemic presents both a great opportunity to generate and communicate technical insights, which could have real and immediate societal impact, and a challenge in allocating and mobilising resources to ensure a balance of short-term responsive issues and longer term developmental and strategic goals are being met.

(more…)

Covid-19 and the chance to build back better for mental health

Shirah M Zirabamuzale23 November 2020

My doctoral project on Sustainable and Responsible Innovation in Mental Health (SRIMH) investigates the feasibility and utility of healthcare policies and architectures that on one hand promote mental health through patient-centric designs and design responsibility, and on the other through sustainable and thoughtful environmental design embedding regenerative and adaptive reuse/preservation strategies. Mental illnesses are increasingly recognised as a leading cause of disability worldwide, yet many countries have fragmented funding models, policy structures and physical infrastructures. Mental well-being affects community spirit, education and the economy, making it a priority for governments worldwide.

Mural of cupped hands

Photo by Tim Mossholder on Unsplash

The COVID-19 pandemic has disrupted and, in some cases, halted critical mental health services in 93% of countries worldwide yet the demand for mental health is increasing, as highlighted in a recent WHO survey. The survey of 130 countries provides the first global data showing the devastating impact of COVID-19 on access to mental health services and underscores the urgent need for increased funding, technological innovation and policy interventions that advance the role of the built environment and SRIMH in improving mental health for citizens.

(more…)

COVID-19: IoT and Cybersecurity

fredrikskippervold27 August 2020

Fredrik Johan Skippervold is a UCL MPA Graduate within Digital Technologies and Policy 18/19. He holds a Bachelor of Law with Spanish and is currently a researcher in the PETRAS National Centre of Excellence for IoT Systems Cybersecurity.

Introduction

Over the past four months (April – July) my colleague Dr Catherine Wheller and I have been following the impacts of COVID-19 on cybersecurity and the Internet of Things (IoT) within the UK and beyond. The pandemic has inspired a range of IoT innovations to help stop the spread of the virus. We have written weekly landscape briefings (LB) that provide up to date information on the latest developments in this area. In this blog I will talk about how we set about collecting information and how we put together these reports, as well as highlight some of the major developments which include discussions surrounding privacy and ethics. To note, a final summary briefing will be posted alongside this blogpost. The summary, which can be found here, includes a detailed timeline of events, provides an overview of how IoT devices are helping to stop the spread of the virus (UK and globally) and presents discussions around so-called ‘immunity passports’.

Cybersecurity

(more…)

Academic Conferences in Crisis Mode – a verdict

Andreas P Kopp12 June 2020

What works and what doesn’t when conferencing online

Academic conferences are among the most important events for researchers. It is the place where you get to present results and receives feedback, where you can put your own name out there and show your face to the academic world, and where you get to network, meet heroes and heroines, academic crushes, and friends from across the globe. Conferencing is one of the perks of academic life – especially for early career researchers and PhD students, who rely on the networks gained at conferences for knowledge sharing and continued learning, for future collaborations, and above all, for the academic job hunt.

Three out of four conferences I planned to attend in 2020 are now over – one has been cancelled, two were transferred to online conferences. In addition, various workshops I meant to attend in person also ‘went digital’. It is time for some reflections and a verdict about academic conferencing during the current global crisis, the COVID-19 pandemic. These are my personal reflections, and your experience might be different. I think, however, that I capture some general aspects that might have been observed by many colleagues out there.

Coffee at desk

Cosily conferencing at home with better coffee, but less socialising

 

First of all, kudos to the many organisers who in most cases had very little time to change entire conferences to online layouts – it must have been stressful. Yet, it worked just fine most of the time. All the participants usually understand that these are different, challenging times, so nobody takes any hiccups seriously but instead remains patient and calm.

(more…)

Access to Remdesivir for patients in the UK: it won’t be quick or cheap

saheli.burton9 June 2020

Saheli Datta Burton is a Research Fellow in Geopolitics of Industrial IOT Standards, with an interest in the global governance issues of emerging medical technologies. 

Gilead’s drug Remdesivir is increasingly being endorsed by various governments as an aid for improving recovery times in COVID-19 patients. Just last week, the Australian government endorsed Remdesivir as an aid to recovery. A week earlier, the drug was made available in the UK for compassionate use in emergency situations via the Early Access to Medicines Scheme (EAMS) based on a 1-year provisional licensing arrangement between the NHS and Gilead. EAMS allowed doctors in the UK to administer Remdesivir outside the ongoing clinical trials without being penalised for malpractice.

Novel Coronavirus SARS-CoV-2

Novel Coronavirus SARS-CoV-2 by NIAID

The question is what will happen after the EAMS’ provisional license runs out in a years time? Can patients in UK still receive the drug? The answer depends on the price. Or, more precisely, on Gilead’s ‘rich country’ price mark-up for UK patients. And the higher the price, the longer it will take to become available to patients. Here’s why.

(more…)